154 related articles for article (PubMed ID: 37792757)
1. HIGH-DENSITY LIPOPROTEIN CHOLESTEROL AND SYSTEMIC ARTERIAL HYPERTENSION ARE ASSOCIATED WITH HEPATIC NECROINFLAMMATORY ACTIVITY IN PATIENTS WITH CHRONIC HEPATITIS C.
Souza GHPE; Silva LD; Vieira DA; Rocha GA; Lima AS; Vidigal PVT
Arq Gastroenterol; 2023; 60(3):287-299. PubMed ID: 37792757
[TBL] [Abstract][Full Text] [Related]
2. Association of Serum Lipids with Hepatic Steatosis, Stage of Liver Fibrosis and Viral Load in Chronic Hepatitis C.
Valkov I; Ivanova R; Alexiev A; Antonov K; Mateva L
J Clin Diagn Res; 2017 Aug; 11(8):OC15-OC20. PubMed ID: 28969178
[TBL] [Abstract][Full Text] [Related]
3. Effects of HCV Clearance with Direct-Acting Antivirals (DAAs) on Liver Stiffness, Liver Fibrosis Stage and Metabolic/Cellular Parameters.
Ferreira J; Bicho M; Serejo F
Viruses; 2024 Feb; 16(3):. PubMed ID: 38543737
[TBL] [Abstract][Full Text] [Related]
4. Visceral adiposity index is associated with histological findings and high viral load in patients with chronic hepatitis C due to genotype 1.
Petta S; Amato M; Cabibi D; Cammà C; Di Marco V; Giordano C; Galluzzo A; Craxì A
Hepatology; 2010 Nov; 52(5):1543-52. PubMed ID: 20799355
[TBL] [Abstract][Full Text] [Related]
5. Effects of patient factors on noninvasive liver stiffness measurement using acoustic radiation force impulse elastography in patients with chronic hepatitis C.
Chen SH; Li YF; Lai HC; Kao JT; Peng CY; Chuang PH; Su WP; Chiang IP
BMC Gastroenterol; 2012 Aug; 12():105. PubMed ID: 22877310
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of diagnostic accuracy of APRI for prediction of fibrosis in hepatitis C patients.
Khan DA; Fatima-Tuz-Zuhra ; Khan FA; Mubarak A
J Ayub Med Coll Abbottabad; 2008; 20(4):122-6. PubMed ID: 19999223
[TBL] [Abstract][Full Text] [Related]
7. Hyperuricaemia: another metabolic feature affecting the severity of chronic hepatitis because of HCV infection.
Petta S; Macaluso FS; Cammà C; Marco VD; Cabibi D; Craxì A
Liver Int; 2012 Oct; 32(9):1443-50. PubMed ID: 22764879
[TBL] [Abstract][Full Text] [Related]
8. Steatosis affects the performance of liver stiffness measurement for fibrosis assessment in patients with genotype 1 chronic hepatitis C.
Macaluso FS; Maida M; Cammà C; Cabibbo G; Cabibi D; Alduino R; Di Marco V; Craxì A; Petta S
J Hepatol; 2014 Sep; 61(3):523-9. PubMed ID: 24815874
[TBL] [Abstract][Full Text] [Related]
9. Transmembrane 6 superfamily member 2 gene E167K variant impacts on steatosis and liver damage in chronic hepatitis C patients.
Milano M; Aghemo A; Mancina RM; Fischer J; Dongiovanni P; De Nicola S; Fracanzani AL; D'Ambrosio R; Maggioni M; De Francesco R; Fargion S; Berg T; Stickel F; Hampe J; Romeo S; Colombo M; Valenti L
Hepatology; 2015 Jul; 62(1):111-7. PubMed ID: 25820484
[TBL] [Abstract][Full Text] [Related]
10. Elevated serum CK18 levels in chronic hepatitis C patients are associated with advanced fibrosis but not steatosis.
Jazwinski AB; Thompson AJ; Clark PJ; Naggie S; Tillmann HL; Patel K
J Viral Hepat; 2012 Apr; 19(4):278-82. PubMed ID: 22404726
[TBL] [Abstract][Full Text] [Related]
11. Influence of steatosis on progression of fibrosis and virological response in chronic hepatitis C cases.
Rafi H; Kabbaj N; Salihoun M; Amrani L; Acharki M; Guedira M; Nya M; Amrani N
Arab J Gastroenterol; 2011 Sep; 12(3):136-8. PubMed ID: 22055591
[TBL] [Abstract][Full Text] [Related]
12. Etiology-related determinants of liver stiffness values in chronic viral hepatitis B or C.
Fraquelli M; Rigamonti C; Casazza G; Donato MF; Ronchi G; Conte D; Rumi M; Lampertico P; Colombo M
J Hepatol; 2011 Apr; 54(4):621-8. PubMed ID: 21146243
[TBL] [Abstract][Full Text] [Related]
13. The hepatic expression of vitamin D receptor is inversely associated with the severity of liver damage in genotype 1 chronic hepatitis C patients.
Petta S; Grimaudo S; Tripodo C; Cabibi D; Calvaruso M; Di Cristina A; Guarnotta C; Macaluso FS; Minissale MG; Marchesini G; Craxì A
J Clin Endocrinol Metab; 2015 Jan; 100(1):193-200. PubMed ID: 25268393
[TBL] [Abstract][Full Text] [Related]
14. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis.
Gaia S; Carenzi S; Barilli AL; Bugianesi E; Smedile A; Brunello F; Marzano A; Rizzetto M
J Hepatol; 2011 Jan; 54(1):64-71. PubMed ID: 20932598
[TBL] [Abstract][Full Text] [Related]
15. Circulating vascular adhesion protein-1(VAP-1): a possible biomarker for liver fibrosis associated with chronic hepatitis B and C.
Öksüz Z; Üçbilek E; Serin MS; Yaraş S; Temel GO; Sezgin O
Braz J Microbiol; 2020 Dec; 51(4):1757-1763. PubMed ID: 32959205
[TBL] [Abstract][Full Text] [Related]
16. Industrial, not fruit fructose intake is associated with the severity of liver fibrosis in genotype 1 chronic hepatitis C patients.
Petta S; Marchesini G; Caracausi L; Macaluso FS; Cammà C; Ciminnisi S; Cabibi D; Porcasi R; Craxì A; Di Marco V
J Hepatol; 2013 Dec; 59(6):1169-76. PubMed ID: 23933265
[TBL] [Abstract][Full Text] [Related]
17. Insulin resistance: a major factor associated with significant liver fibrosis in Egyptian patients with genotype 4 chronic hepatitis C.
El Ray A; Asselah T; Moucari R; El Ghannam M; Taha AA; Saber MA; Akl M; Atta R; Shemis M; Radwan AS; Ghali A; Paradis V; Marcellin P
Eur J Gastroenterol Hepatol; 2013 Apr; 25(4):421-7. PubMed ID: 23470266
[TBL] [Abstract][Full Text] [Related]
18. Globulin-platelet model predicts minimal fibrosis and cirrhosis in chronic hepatitis B virus infected patients.
Liu XD; Wu JL; Liang J; Zhang T; Sheng QS
World J Gastroenterol; 2012 Jun; 18(22):2784-92. PubMed ID: 22719186
[TBL] [Abstract][Full Text] [Related]
19. The validity of serum markers for fibrosis staging in chronic hepatitis B and C.
Li J; Gordon SC; Rupp LB; Zhang T; Boscarino JA; Vijayadeva V; Schmidt MA; Lu M;
J Viral Hepat; 2014 Dec; 21(12):930-7. PubMed ID: 24472062
[TBL] [Abstract][Full Text] [Related]
20. Should a liver biopsy be done in patients with subclinical chronically elevated transaminases?
de Lédinghen V; Combes M; Trouette H; Winnock M; Amouretti M; de Mascarel A; Couzigou P
Eur J Gastroenterol Hepatol; 2004 Sep; 16(9):879-83. PubMed ID: 15316412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
